The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer.
 
Vaibhav G. Patel
No Relationships to Disclose
 
Xiaobo Zhong
No Relationships to Disclose
 
Neil J. Shah
No Relationships to Disclose
 
Luis Pina Martina
No Relationships to Disclose
 
Jessica Hawley
Research Funding - Dendreon; Regeneron
Travel, Accommodations, Expenses - Genzyme
 
Emily Lin
No Relationships to Disclose
 
Benjamin Adam Gartrell
No Relationships to Disclose
 
Victor Ricardo Adorno Febles
No Relationships to Disclose
 
David R Wise
Employment - Best Doctors, Inc
Honoraria - OncLive
Consulting or Advisory Role - Alphasights; Foundation Medicine; Gerson Lehrman Group; Guidepoint Global; Leap Therapeutics; Pfizer; Silverlight
Travel, Accommodations, Expenses - Pfizer
 
Qian Qin
No Relationships to Disclose
 
George Mellgard
No Relationships to Disclose
 
Jones T. Nauseef
No Relationships to Disclose
 
David Green
No Relationships to Disclose
 
Panagiotis J. Vlachostergios
No Relationships to Disclose
 
Daniel Kwon
No Relationships to Disclose
 
Franklin W. Huang
No Relationships to Disclose
 
Bobby Chi-Hung Liaw
Consulting or Advisory Role - Amgen; Baxter; Genomic Health
Research Funding - Bayer; Janssen; Sanofi
 
Scott T. Tagawa
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Dendreon; Endocyte; Genentech; Genomic Health; Immunomedics; Janssen; Karyopharm Therapeutics; Medivation; Novartis; Pfizer; POINT Biopharma; QED Therapeutics; Sanofi; Tolmar
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Amgen; Immunomedics; Sanofi
(OPTIONAL) Uncompensated Relationships - ATLAB Pharma; Phosplatin Therapeutics; Telix Pharmaceuticals
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Curium Pharma; Curium Pharma; Endocyte; Johnson & Johnson; ORIC Pharmaceuticals
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Endocyte; Fujifilm
 
William K. Oh
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bayer; Conjupro Biotherapeutics; Foundry; HUYA Bioscience International; Janssen; Sanofi; Sema4; TeneoBio